Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Frontiers in Oncology
|
April 30, 2025
Haploidentical, matched-related, and matched-unrelated hematopoietic cell transplant for acute leukemias in the early years of haploidentical transplant implementation in a developing country with a large unrelated donor registry
Adriana Seber, Leonardo Javier Arcuri, Vergilio Rensi Colturato, et al.
Ejhaem
|
October 16, 2025
Standardization of Measurable Residual Disease in Acute Myeloid Leukemia by Flow Cytometry: A Multicenter Study
Maura Rosane Valerio Ikoma-Colturato, Felipe Magalhães Furtado, Camila Marques Bertolucci, et al.
Bone Marrow Transplantation
|
April 1, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee
Christopher Armstrong, Kavita Raj, Giorgia Battipaglia, et al.
The Lancet. Haematology
|
June 4, 2026
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
Carmelo Gurnari, Chris Armstrong, Giorgia Battipaglia, et al.
Transplantation and Cellular Therapy
|
April 22, 2026
Outcomes of Allogeneic Hematopoietic Cell Transplantation for Hypoplastic Myelodysplastic Syndrome: A Latin American Multicenter Analysis
Fernando Barroso Duarte, Yhasmine Delles Oliveira Garcia, Maria Cristina Martins de Almeida Macedo, et al.
Transplantation and Cellular Therapy
|
June 20, 2026
Haploidentical versus HLA-Matched Unrelated Donors for Hematopoietic Cell Transplantation in Acute Leukemia: A Multicenter Observational Study in a Developing Country Facilitated by Collaboration between the CIBMTR and the Brazilian Society of Cellular Therapy and Bone Marrow Transplantation (SBTMO)
Mariana Nassif Kerbauy, Leonardo Javier Arcuri, Vergilio Antonio Rensi Colturato, et al.
Blood
|
February 19, 2025
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
Carmelo Gurnari, Marie Robin, Lionel Adès, et al.
Journal of Global Oncology
|
November 28, 2019
Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study
Vania Tietsche de Moraes Hungria, Carlos Chiattone, Miguel Pavlovsky, et al.
European Journal of Haematology
|
June 26, 2025
Outcomes After Allogeneic Hematopoietic Cell Transplantation in Adults With Myelodysplastic Syndrome With 65 Years or Older Compared to Youngers. A Retrospective Analysis of the Latin America Registry
Fernando Barroso Duarte, Yhasmine Delles Oliveira Garcia, Vaneuza Araújo Moreira Funke, et al.
Bone Marrow Transplantation
|
April 24, 2026
Patients with myelodysplastic/myeloproliferative neoplasms have higher rates of relapse following allogeneic hematopoietic cell transplantation compared to those with MDS: A Brazilian SBTMO/CIBMTR registry analysis
Fernando Barroso Duarte, Yhasmine Delles Oliveira Garcia, Vanderson Rocha, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Frontiers in Oncology
|
April 30, 2025
Haploidentical, matched-related, and matched-unrelated hematopoietic cell transplant for acute leukemias in the early years of haploidentical transplant implementation in a developing country with a large unrelated donor registry
Adriana Seber, Leonardo Javier Arcuri, Vergilio Rensi Colturato, et al.
Ejhaem
|
October 16, 2025
Standardization of Measurable Residual Disease in Acute Myeloid Leukemia by Flow Cytometry: A Multicenter Study
Maura Rosane Valerio Ikoma-Colturato, Felipe Magalhães Furtado, Camila Marques Bertolucci, et al.
Bone Marrow Transplantation
|
April 1, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee
Christopher Armstrong, Kavita Raj, Giorgia Battipaglia, et al.
The Lancet. Haematology
|
June 4, 2026
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
Carmelo Gurnari, Chris Armstrong, Giorgia Battipaglia, et al.
Transplantation and Cellular Therapy
|
April 22, 2026
Outcomes of Allogeneic Hematopoietic Cell Transplantation for Hypoplastic Myelodysplastic Syndrome: A Latin American Multicenter Analysis
Fernando Barroso Duarte, Yhasmine Delles Oliveira Garcia, Maria Cristina Martins de Almeida Macedo, et al.
Transplantation and Cellular Therapy
|
June 20, 2026
Haploidentical versus HLA-Matched Unrelated Donors for Hematopoietic Cell Transplantation in Acute Leukemia: A Multicenter Observational Study in a Developing Country Facilitated by Collaboration between the CIBMTR and the Brazilian Society of Cellular Therapy and Bone Marrow Transplantation (SBTMO)
Mariana Nassif Kerbauy, Leonardo Javier Arcuri, Vergilio Antonio Rensi Colturato, et al.
Blood
|
February 19, 2025
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
Carmelo Gurnari, Marie Robin, Lionel Adès, et al.
Journal of Global Oncology
|
November 28, 2019
Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study
Vania Tietsche de Moraes Hungria, Carlos Chiattone, Miguel Pavlovsky, et al.
European Journal of Haematology
|
June 26, 2025
Outcomes After Allogeneic Hematopoietic Cell Transplantation in Adults With Myelodysplastic Syndrome With 65 Years or Older Compared to Youngers. A Retrospective Analysis of the Latin America Registry
Fernando Barroso Duarte, Yhasmine Delles Oliveira Garcia, Vaneuza Araújo Moreira Funke, et al.
Bone Marrow Transplantation
|
April 24, 2026
Patients with myelodysplastic/myeloproliferative neoplasms have higher rates of relapse following allogeneic hematopoietic cell transplantation compared to those with MDS: A Brazilian SBTMO/CIBMTR registry analysis
Fernando Barroso Duarte, Yhasmine Delles Oliveira Garcia, Vanderson Rocha, et al.
Page
of 8